Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Jacob

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Glycobiology|June 18, 2004
Structure and function of vertebrate CMP-sialic acid synthetasesAnja K Münster-Kühnel, Joe Tiralongo, Stephan Krapp, et al.
Journal of Molecular Biology|November 26, 2003
The crystal structure of murine CMP-5-N-acetylneuraminic acid synthetaseStephan Krapp, Anja K Münster-Kühnel, Jens T Kaiser, et al.
The Journal of Biological Chemistry|February 17, 2007
Open and closed structures of the UDP-glucose pyrophosphorylase from Leishmania majorThomas Steiner, Anne-Christin Lamerz, Petra Hess, et al.
Journal of Translational Medicine|November 19, 2013
NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2Todd A Braciak, Sarah Wildenhain, Claudia C Roskopf, et al.
The Journal of Biological Chemistry|May 20, 2004
Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agentsAndrea Schweinitz, Torsten Steinmetzer, Ingo J Banke, et al.
Oncotarget|November 9, 2016
CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cellsChristian B Schiller, Todd A Braciak, Nadja C Fenn, et al.
Oncoimmunology|September 20, 2018
Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cellsTodd A Braciak, Claudia C Roskopf, Sarah Wildenhain, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Glycobiology|June 18, 2004
Structure and function of vertebrate CMP-sialic acid synthetasesAnja K Münster-Kühnel, Joe Tiralongo, Stephan Krapp, et al.
Journal of Molecular Biology|November 26, 2003
The crystal structure of murine CMP-5-N-acetylneuraminic acid synthetaseStephan Krapp, Anja K Münster-Kühnel, Jens T Kaiser, et al.
The Journal of Biological Chemistry|February 17, 2007
Open and closed structures of the UDP-glucose pyrophosphorylase from Leishmania majorThomas Steiner, Anne-Christin Lamerz, Petra Hess, et al.
Journal of Translational Medicine|November 19, 2013
NK cells from an AML patient have recovered in remission and reached comparable cytolytic activity to that of a healthy monozygotic twin mediated by the single-chain triplebody SPM-2Todd A Braciak, Sarah Wildenhain, Claudia C Roskopf, et al.
The Journal of Biological Chemistry|May 20, 2004
Design of novel and selective inhibitors of urokinase-type plasminogen activator with improved pharmacokinetic properties for use as antimetastatic agentsAndrea Schweinitz, Torsten Steinmetzer, Ingo J Banke, et al.
Oncotarget|November 9, 2016
CD19-specific triplebody SPM-1 engages NK and γδ T cells for rapid and efficient lysis of malignant B-lymphoid cellsChristian B Schiller, Todd A Braciak, Nadja C Fenn, et al.
Oncoimmunology|September 20, 2018
Dual-targeting triplebody 33-16-123 (SPM-2) mediates effective redirected lysis of primary blasts from patients with a broad range of AML subtypes in combination with natural killer cellsTodd A Braciak, Claudia C Roskopf, Sarah Wildenhain, et al.
Pageof 2